Download PDF
Thromb Haemost 2013; 110(04): 632-633
DOI: 10.1160/TH13-08-0685
Theme Issue Editorial
Schattauer GmbH

Obesity and vascular disease: From bench to bedside

Marie-Christine Alessi
1   Laboratoire d’Hématologie, Inserm UMR 1062, Faculté de Médecine, Université Aix Marseille, Marseille, France
,
Johann Wojta
2   Department of Internal Medicine II, Medical University of Vienna, Vienna, Austria
3   Core Facilities, Medical University of Vienna, Vienna, Austria
4   Ludwig Boltzmann Cluster for Cardiovascular Research, Vienna, Austria
› Author Affiliations
Further Information

Publication History

Received: 20 August 2013

Accepted: 20 August 2013

Publication Date:
01 December 2017 (online)

    Permissions and Reprints

 

 

  • References

  • 1 Swinburn BA, Sacks G, Hall KD. et al. The global obesity pandemic: shaped by global drivers and local environments.. Lancet 2011; 378: 804-814.
    CrossrefPubMedGoogle Scholar
  • 2 Must A, Spadano J, Coakley EH. et al. The disease burden associated with overweight and obesity.. J Am Med Assoc 1999; 282: 1523-1529.
    CrossrefPubMedGoogle Scholar
  • 3 Pischon T, Boeing H, Hoffmann K. et al. General and abdominal adiposity and risk of death in Europe.. N Engl J Med 2008; 359: 2105-2120.
    CrossrefPubMedGoogle Scholar
  • 4 Go AS, Mozaffarian D, Roger VL. et al. Heart disease and stroke statistics—2013 update: a report from the American Heart Association.. Circulation 2013; 127: e6-e245.
    CrossrefPubMedGoogle Scholar
  • 5 Wattanakit K, Lutsey PL, Bell EJ. et al. Association between cardiovascular disease risk factors and occurrence of venous thromboembolism. A time-dependent analysis.. Thromb Haemost 2012; 108: 508-515.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 6 Hamer M, Stamatakis E. Metabolically healthy obesity and risk of all-cause and cardiovascular disease mortality.. J Clin Endocrinol Metab 2012; 97: 2482-2488.
    CrossrefPubMedGoogle Scholar
  • 7 Bluher M. Are there still healthy obese patients?. Curr Opin Endocrinol Diabetes Obes 2012; 19: 341-346.
    CrossrefPubMedGoogle Scholar
  • 8 Scroyen I, Hemmeryckx B, Lijnen HR. From mice to men: mouse models in obesity research: What can we learn?. Thromb Haemost 2013; 110: 634-640.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 9 Zhao L. The gut microbiota and obesity: from correlation to causality.. Nat Rev Microbiol. 2013 Epub ahead of print.
    PubMedGoogle Scholar
  • 10 Frontin A, Cinti S. Distribution and development of brown adipocytes in the murine and human adipose organ.. Cell Metab 2010; 11: 235-236.
    PubMedGoogle Scholar
  • 11 Chmelar J, Chung KJ, Chavakis T. The role of innate immune cells in obese adipose tissue inflammation and development of insulin resistance.. Thromb Haemost 2013; 109: 399-406.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 12 Rega-Kaun G, Kaun C, Wojta J. More than a simple storage organ: Adipose tissue as a source of adipokines involved in cardiovascular disease.. Thromb Haemost 2013; 110: 641-650.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 13 Morelli M, Gaggini M, Daniele G. et al. Ectopic fat: the true culprit linking obesity and cardiovascular disease?. Thromb Haemost 2013; 110: 651-660.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 14 Lemoine AY, Ledoux S, Larger E. Adipose tissue angiogenesis in obesity.. Thromb Haemost 2013; 110: 661-668.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 15 Morange PE, Alessi MC. Thrombosis in central obesity and metabolic syndrome: Mechanisms and epidemiology.. Thromb Haemost 2013; 110: 669-680.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 16 Badimon L, Hernandez Vera R, Padro T. et al. Antithrombotic therapy in obesity.. Thromb Haemost 2013; 110: 681-688.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 17 van Baak MA. Nutrition as a link between obesity and cardiovascular disease: how can we stop the obesity epidemic?. Thromb Haemost 2013; 110: 689-696.
    Article in Thieme ConnectPubMedGoogle Scholar